National Ambulance Patient Group Directions

National PGDs have been developed for ambulance services commissioned by NHS England.  They are supported by NASMeD and JRCALC. Organisations need to adopt them locally in…

Patient Group Directions for Chemical, Biological, Radiological and Nuclear (CBRN) incidents

A specific set of PGDs have been developed by Public Health England (PHE) in partnership with NHS England, the Department of Health and Social Care…

Regional Medicines Optimisation Committee Antidotes and RUMs Position Statement

Attached is the final position statement produced by the London RMOC on access to and availability of antidotes and rarely used medicines (RUMs) published in…

Shortage of salbutamol injection 500 micrograms (0.5mg) in 1ml (Ventolin®)

GSK, the sole supplier of salbutamol injection, has reported a problem with supply, predicted to be from 5th March until week commencing 16th March. This…

Shortage of hydrocortisone 100 mg/mL or 500mg/5ml Injection

The supplier of hydrocortisone sodium phosphate injection (formerly Efcortesol) is currently out of stock due to an issue with the active pharmaceutical ingredient. Further supplies…

Shortage of Diazemuls (diazepam 5mg/ml emulsion for injection)

There is a shortage of Diazemuls until mid-August 2018 (2.5mg diazepam rectal tubes also out of stock until mid-June 2018).  This memo provides advice on…

What naloxone doses should be used in adults to reverse urgently the effects of opioids or opiates?

The opioid and opiate antagonist, naloxone, is a highly effective antidote the use of which is potentially life-saving. The drug has a role in a…

In use product safety assessment report: naloxone products for emergency opiate reversal in non-medical settings

A UKMi Product Safety assessment on naloxone products for emergency opiate reversal in non-medical settings; in-use medication safety considerations resultant from the product presentation or…